Viokace (Allergan, Inc.)
Welcome to the PulseAid listing for the Viokace drug offered from Allergan, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc. |
| NON-PROPRIETARY NAME: | Pancrelipase |
| SUBSTANCE NAME: | PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE; PANCRELIPASE AMYLASE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-03-01 |
| END MARKETING DATE: | 0000-00-00 |
Viokace HUMAN PRESCRIPTION DRUG Details:
| Item Description | Viokace from Allergan, Inc. |
| LABELER NAME: | Allergan, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10440; 39150; 39150([USP’U]/1; [USP’U]/1; [USP’U]/1) |
| START MARKETING DATE: | 2012-03-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 58914-112_13dbf16d-db0e-4f1f-ac43-7a2badf8170f |
| PRODUCT NDC: | 58914-112 |
| APPLICATION NUMBER: | NDA022542 |
Other PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE; PANCRELIPASE AMYLASE Pharmaceutical Manufacturers / Labelers:
